The Synovitis, Acne, Pustulosis, Hyperostosis, And Osteitis (SAPHO) syndrome: A two-center study of 23 patients

Egyptian Rheumatologist - Tập 44 - Trang 41-46 - 2022
Kaouther Maatallah1,2, Khaoula Zouaoui3,2, Hanene Ferjani1,2, Rim Dhahri3,2, Leila Metoui3,2, Dorra Ben Nessib1,2, Maroua Slouma3,2, Wafa Triki1,2, Dhia Kaffel1,2, Wafa Hamdi1,2, Imen Gharsallah3,2
1Department of Rheumatology, Kassab Institute of Orthopedics, Manouba, Tunisia
2Faculty of Medicine of Tunis, University Tunis el Manar, Tunis, Tunisia
3Department of Rheumatology, The Military Hospital of Tunis, Tunis, Tunisia

Tài liệu tham khảo

Benhamou, 1988, Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies?, Clin Exp Rheumatol, 6, 109 Aljuhani, 2015, The SAPHO syndrome: a single-center study of 41 adult patients, J Rheumatol, 42, 329, 10.3899/jrheum.140342 Nguyen, 2012, The SAPHO syndrome, Semin Arthritis Rheum, 42, 254, 10.1016/j.semarthrit.2012.05.006 Rukavina, 2015, SAPHO syndrome: a review, J Child Orthop, 9, 19, 10.1007/s11832-014-0627-7 Firinu, 2016, SAPHO syndrome: current developments and approaches to clinical treatment, CurrRheumatol Rep, 18, 35 Gharsallah, 2014, SAPHO syndrome, Rev Med Interne, 35, 595, 10.1016/j.revmed.2013.12.018 Hayem, 1999, SAPHO syndrome: a long-term follow-up study of 120 cases, Semin Arthritis Rheum, 29, 159, 10.1016/S0049-0172(99)80027-4 Van Doornum, 2000, SAPHO: rare or just not recognized?, Semin Arthritis Rheum, 30, 70, 10.1053/sarh.2000.8371 Assmann, 2009, Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study, Arthritis Res Ther, 11, R140, 10.1186/ar2812 Burgemeister, 2012, Biologics for rare inflammatory diseases: TNF blockade in the SA PHO syndrome, Neth J Med, 70, 444 Assmann, 2010, Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome, Rheumatol Int, 30, 1273, 10.1007/s00296-009-1136-8 Hurtado-Nedelec, 2008, Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome, Rheumatology (Oxford), 47, 1160, 10.1093/rheumatology/ken185 Claudepierre, 1996, SAPHO syndrome and pyoderma gangrenosum: is it fortuitous?, J Rheumatol, 23, 400 Edwards, 1986, Sweet's syndrome with multifocal sterile osteomyelitis, Am J Dis Child, 140, 817 DiMeco F, Clatterbuck RE, Li KW, McCarthy EF, Olivi A. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome presenting as a primary calvarial lesion. Case report and review of the literature. J Neurosurg. 2000;93(4):693-7. Eyrich, 2000, Diffuse chronic sclerosing osteomyelitis and the synovitis, acne, pustolosis, hyperostosis, osteitis (SAPHO) syndrome in two sisters, Int J Oral Maxillofac Surg, 29, 49, 10.1016/S0901-5027(00)80125-3 Aubry-Rozier, 2012, Diffuse sclerosing osteomyelitis of the mandible and SAPHO, Rev Med Int, 33, e34, 10.1016/j.revmed.2011.07.011 Colina, 2009, Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects, Arthritis Rheum, 61, 813, 10.1002/art.24540 Yabe, 2010, Mucosal lesions may be a minor complication of SAPHO syndrome: a study of 11 Japanese patients with SAPHO syndrome, Rheumatol Int, 30, 1277, 10.1007/s00296-009-1138-6 Fritz, 2009, Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data, Radiology, 252, 842, 10.1148/radiol.2523081335 Parlier-Cuau, 2010, Vertebral involvement in SAPHO syndrome, J Radiol, 91, 1068, 10.1016/S0221-0363(10)70151-7 Thakur, 2012, Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) and chronic recurrent multifocal osteomyelitis (CRMO): role of imaging in diagnosis, Radiography, 18, 221, 10.1016/j.radi.2011.11.001 Daoussis, 2019, Biologics in SAPHO syndrome: a systematic review, Semin Arthritis Rheum, 48, 618, 10.1016/j.semarthrit.2018.04.003 Massara, 2006, In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations, Rheumatology (Oxford), 45, 730, 10.1093/rheumatology/kei221 Ben Abdelghani, 2010, Tumor necrosis factor-alpha blockers in SAPHO syndrome, J Rheumatol, 37, 1699, 10.3899/jrheum.091086 Amital, 2004, SAPHO syndrome treated with pamidronate: an open-label study of 10 patients, Rheumatology (Oxford), 43, 658, 10.1093/rheumatology/keh149 Rozin, 2007, Is SAPHO syndrome a target for antibiotic therapy?, Clin Rheumatol, 26, 817, 10.1007/s10067-006-0274-6